AtaiBeckley (ATAI) Operating Leases (2022 - 2026)
AtaiBeckley (ATAI) recorded quarterly Operating Leases of $1.7 million in Q1 2026, down 6.16% quarter-over-quarter from $1.8 million in Q4 2025.
AtaiBeckley (ATAI) Operating Leases (2022 - 2026) Analysis & Trends
AtaiBeckley's Operating Leases history runs 3 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- In Q1 2026, Operating Leases changed N/A year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (changed N/A YoY), while the FY2025 annual figure was $1.8 million, up 146.04% from the prior year.
- Operating Leases was $1.7 million for Q1 2026 at AtaiBeckley, down from $1.8 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $2.6 million in Q2 2025 to a low of $44000.0 in Q4 2022.
- The 4-year median for Operating Leases is $1.0 million (2023), against an average of $1.3 million.
- Biggest YoY gain for Operating Leases was 146.04% in 2025; the steepest drop was 146.04% in 2025.
- A 3-year view of Operating Leases shows it stood at $732000.0 in 2024, then soared by 146.04% to $1.8 million in 2025, then decreased by 6.16% to $1.7 million in 2026.
- The last three Operating Leases figures came in at $1.7 million (Q1 2026), $1.8 million (Q4 2025), and $732000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.69 Mn |
| Dec 31, 2025 | 1.80 Mn |
| Sep 30, 2025 | 2.43 Mn |
| Jun 30, 2025 | 2.62 Mn |
| Mar 31, 2025 | 2.59 Mn |
| Dec 31, 2024 | 732,000.00 |
| Dec 31, 2024 | 732,000.00 |
| Sep 30, 2024 | 808,000.00 |
| Jun 30, 2024 | 838,000.00 |
| Mar 31, 2024 | 907,000.00 |
| Dec 31, 2023 | 990,000.00 |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | 44,000.00 |